Investigation of the association of serum GFAP and NfL with brain and upper cervical MRI volumes in AQP4-IgG-positive NMOSD and MOGAD
Background: Serum glial fibrillary acidic protein (sGFAP) is associated with disease activity in aquaporin-4-immunoglobulin G-seropositive neuromyelitis optica spectrum disorders (AQP4-IgG+NMOSD). Serum neurofilament light chain (sNfL) is a biomarker for neuroaxonal damage. However, the association...
Saved in:
| Main Authors: | Patrick Schindler, Ulrike Grittner, Rebekka Rust, Susanna Asseyer, Judith Bellmann-Strobl, Tanja Schmitz-Hübsch, Michael Scheel, Sven Jarius, Brigitte Wildemann, Markus Reindl, Pascal Benkert, Jens Kuhle, Friedemann Paul, Klemens Ruprecht, Claudia Chien |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-07-01
|
| Series: | Therapeutic Advances in Neurological Disorders |
| Online Access: | https://doi.org/10.1177/17562864251345792 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of Neurofilament light (NfL) and glial fibrillary acidic protein (GFAP) in MS and AQP4-NMOSD: Advancing clinical applications.
by: Sara Samadzadeh, et al.
Published: (2025-03-01) -
Clinical applications and diagnostic research of GFAP and NfL in MS and NMOSD: a meta-analysis
by: XueJuan Lin, et al.
Published: (2025-07-01) -
AQP4-IgG NMOSD, MOGAD, and double-seronegative NMOSD: is it possible to depict the antibody subtype using magnetic resonance imaging?
by: Diego Cardoso Fragoso, et al.
Published: (2023-06-01) -
Induction of immune tolerance in NMOSD and MOGAD
by: Jorge Correale, et al.
Published: (2025-07-01) -
A roadmap to increasing access to AQP4-Ig testing for NMOSD: expert recommendations
by: Raquel Vassão-Araujo, et al.
Published: (2025-02-01)